Home » Living Safer: Has Zantac Harmed Public Health? The Alleged Connection Between Ranitidine and Cancer
Living Safer: Has Zantac Harmed Public Health? The Alleged Connection Between Ranitidine and Cancer
We are pleased to announce that the latest issue of Living Safer, your magazine for all things related to safety, is available. Please consider reading our cover story titled:
“After Decades of Use, How Much has Zantac Harmed Public Health?”
Written by Managing Partner Eric Chaffin and Partner Roopal Luhana, the article — published prior to the FDA withdrawal of all Zantac/ranitidine medications — covers important national litigation involving the link between N-Nitrosodimethylamine (NDMA), a known carcinogen, and the popular heartburn medication Zantac, and its generic form ranitidine.
If you’d like to receive future e-releases of our Living Safer Magazine, please complete the form below.
Recent Posts
- Chaffin Luhana’s Thanksgiving Tradition Continues with Community Turkey Giveaways
- Chaffin Luhana LLP Honored as 2024 CrispX Firm of the Year
- Chaffin Luhana Foundation Scholarship Winner Seeks a Safer Future for Her Peers
- Chaffin Luhana LLP Makes the INC 5000 List of Fastest-Growing Private Companies
- Living Safer: The Leading Cause of Preventable Deaths in America: How to Stop Poisoning in Its Tracks